Cargando…

Dose‐response Trial of Lactoferrin in Patients with Chronic Hepatitis C

Hepatitis C virus (HCV) is one of the most common causes of chronic hepatitis. Interferon is presently the only effective treatment for chronic hepatitis C (CH‐C), though its effectiveness is limited. Lactoferrin (LF), which is an 80‐kDa, iron‐binding glycoprotein, has several biological activities...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Shuichi, Tanaka, Katsuaki, Sato, Tosiya, Ueno, Hideki, Saito, Satoru, Okusaka, Takuji, Sato, Keiko, Yamamoto, Seiichiro, Kakizoe, Tadao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927129/ https://www.ncbi.nlm.nih.gov/pubmed/12359061 http://dx.doi.org/10.1111/j.1349-7006.2002.tb02484.x

Ejemplares similares

Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
por: Tanaka, Katsuaki, et al.
Publicado: (1999)

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
por: Suzuki, Eiichiro, et al.
Publicado: (2013)

Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma
por: Shiba, Satoshi, et al.
Publicado: (2012)

Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine
por: Iigo, Masaaki, et al.
Publicado: (2014)

Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses
por: Tamai, Toshiyuki, et al.
Publicado: (2017)

Inhibition of Azoxymethane‐initiated Colon Tumor by Bovine Lactoferrin Administration in F344 Rats
por: Sekine, Kazunori, et al.
Publicado: (1997)

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
por: Ikeda, Masafumi, et al.
Publicado: (2017)

The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancer
por: Satake, Tomoyuki, et al.
Publicado: (2022)

Effect of Heavy Alcohol Intake on Long‐term Results after Curative Resection of Hepatitis C Virus‐related Hepatocellular Carcinoma
por: Okada, Shuichi, et al.
Publicado: (1996)

Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment
por: Okusaka, Takuji, et al.
Publicado: (2016)

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.
por: Okada, S., et al.
Publicado: (1998)

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial
por: Terazawa, Tetsuji, et al.
Publicado: (2014)

Validity of Short‐term Examination for Antipromoters of Bladder Carcinogenesis
por: Kakizoe, Tadao, et al.
Publicado: (1988)

Orthotopic neobladder after cystectomy for bladder cancer
por: KAKIZOE, Tadao
Publicado: (2020)

A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer
por: Kondo, Shunsuke, et al.
Publicado: (2014)

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics
por: Sunakawa, Yu, et al.
Publicado: (2013)

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics
por: Sunakawa, Yu, et al.
Publicado: (2013)

Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
por: Kondo, Shunsuke, et al.
Publicado: (2012)

Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma
por: Kondo, Shunsuke, et al.
Publicado: (2018)

The pain-relieving effects of lactoferrin on oxaliplatin-induced neuropathic pain
por: FUJIMURA, Takeshi, et al.
Publicado: (2020)

Endoscopic ultrasound-guided hepaticojejunostomy for drainage of the right posterior hepatic duct enabled total liver drainage
por: Takeshita, Kotaro, et al.
Publicado: (2023)

Competitive-Level Differences in Trunk and Foot Kinematics of Underwater Undulatory Swimming
por: Tanaka, Takahiro, et al.
Publicado: (2022)

Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
por: Wang, Wen‐Ping, et al.
Publicado: (2000)

CHEMICAL CARCINOGENESIS IN ANALBUMINEMIC RATS
por: Kakizoe, Tadao, et al.
Publicado: (1988)

Lactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
por: Legrand, D., et al.
Publicado: (2005)

Myopia Is Suppressed by Digested Lactoferrin or Holo-Lactoferrin Administration
por: Liang, Yifan, et al.
Publicado: (2023)

An Introduction to Epidemiologic and Statistical Methods Useful in Environmental Epidemiology
por: Nitta, Hiroshi, et al.
Publicado: (2010)

Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NET(®) in Japan
por: Komamine, Maki, et al.
Publicado: (2023)

Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin
por: Mancinelli, Romina, et al.
Publicado: (2020)

Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
por: Hagihara, Atsushi, et al.
Publicado: (2014)

Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold
por: Shin, Kouichirou, et al.
Publicado: (2018)

Impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression: protocol for a cohort study
por: Ito, Hiroto, et al.
Publicado: (2015)

Erratum to: Impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression: protocol for a cohort study
por: Ito, Hiroto, et al.
Publicado: (2017)

Optimal dose of lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies
por: Hussan, Jagir R., et al.
Publicado: (2022)

Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials
por: Koyama, Takafumi, et al.
Publicado: (2019)

Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer
por: Gotoda, Takuji, et al.
Publicado: (1998)

Chemopreventive Effect of Bovine Lactoferrin on 4‐Nitroquinoline 1‐Oxide‐induced Tongue Carcinogenesis in Male F344 Rats
por: Tanaka, Takuji, et al.
Publicado: (2000)

Trial to Induce Prostatic Cancer in ACI/Seg Rats Treated with a Combination of 3,2′‐Dimethyl‐4‐aminobiphenyl and Ethinyl Estradiol
por: Takai, Kazuhiro, et al.
Publicado: (1991)

Role of LRP1 and ERK and cAMP Signaling Pathways in Lactoferrin-Induced Lipolysis in Mature Rat Adipocytes
por: Ikoma-Seki, Keiko, et al.
Publicado: (2015)

Suppressive Role of Lactoferrin in Overweight-Related Female Fertility Problems
por: Sato, Ban, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97thhpiknvradu26nvndrv3fmc